Price
$7.73
Decreased by -2.77%
Dollar volume (20D)
3.17 M
ADR%
9.59
Shares float
7.37 M
Shares short
9.08 K [0.12%]
Shares outstanding
7.37 M
Market cap
170.53 M
Beta
N/A
Price/earnings
N/A
20D range
5.25 8.00
50D range
4.02 8.00
200D range
3.51 8.00

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.

The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name.

It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment.

The company was founded in 2019 and is based in Singapore.

Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte.

Ltd.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY